European Biotechs Question Sustainability Of Platform Technologies
Executive Summary
European biotech companies are facing the question of whether they can sustain themselves over the long-term by focusing on a single platform technology, Ernst & Young suggested in its sixth annual report on the European Life Sciences Industry.